{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:24:00Z","timestamp":1787495040848,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40744-021-00347-3","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T11:03:02Z","timestamp":1629802982000},"page":"1565-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis"],"prefix":"10.1007","volume":"8","author":[{"given":"Katja","family":"Blaschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fischer-Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Dombrowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Joeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Heidbrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"347_CR1","first-page":"541","volume":"89","author":"F Salaffi","year":"2019","unstructured":"Salaffi F, Di Carlo M, Carotti M, Farah S, Ciapetti A, Gutierrez M. The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values. Acta Biomed. 2019;89:541\u201357.","journal-title":"Acta Biomed"},{"key":"347_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/RHU.0000000000000589","volume":"23","author":"V Strand","year":"2017","unstructured":"Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23:383\u201391.","journal-title":"J Clin Rheumatol"},{"key":"347_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4103\/2229-5178.193908","volume":"7","author":"R Sarkar","year":"2016","unstructured":"Sarkar R, Chugh S, Bansal S. General measures and quality of life issues in psoriasis. Indian Dermatol Online J. 2016;7:481\u20138.","journal-title":"Indian Dermatol Online J"},{"key":"347_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03009740903449313","volume":"39","author":"K Mitchell","year":"2010","unstructured":"Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in pregnancy. Scand J Rheumatol. 2010;39:99\u2013108.","journal-title":"Scand J Rheumatol"},{"key":"347_CR5","first-page":"83","volume":"5","author":"GA Vena","year":"2015","unstructured":"Vena GA, Cassano N, Bellia G, Colombo D. Psoriasis in pregnancy: challenges and solutions. Psoriasis (Auckl). 2015;5:83\u201395.","journal-title":"Psoriasis (Auckl)"},{"key":"347_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/acr.24130","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2020;72:461\u201388.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"347_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2796.2010.02239.x","volume":"268","author":"M N\u00f8rgaard","year":"2010","unstructured":"N\u00f8rgaard M, Larsson H, Pedersen L, et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med. 2010;268:329\u201337.","journal-title":"J Intern Med"},{"key":"347_CR8","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3899\/jrheum.140583","volume":"42","author":"B Bharti","year":"2015","unstructured":"Bharti B, Lee SJ, Lindsay SP, et al. Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of teratology information specialists autoimmune diseases in pregnancy project. J Rheumatol. 2015;42:1376\u201382.","journal-title":"J Rheumatol"},{"key":"347_CR9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/rheumatology\/key053","volume":"57","author":"A Zbinden","year":"2018","unstructured":"Zbinden A, van den Brandt S, \u00d8stensen M, Villiger PM, F\u00f6rger F. Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters. Rheumatology (Oxford). 2018;57:1235\u201342.","journal-title":"Rheumatology (Oxford)"},{"key":"347_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2340\/00015555-2923","volume":"98","author":"G Br\u00f6ms","year":"2018","unstructured":"Br\u00f6ms G, Haerskjold A, Granath F, Kieler H, Pedersen L, Berglind IA. Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden. Acta Derm Venereol. 2018;98:728\u201334.","journal-title":"Acta Derm Venereol"},{"key":"347_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3899\/jrheum.171218","volume":"45","author":"M Berman","year":"2018","unstructured":"Berman M, Zisman D, Wollman J, et al. The effect of pregnancy on disease activity in patients with psoriatic arthritis. J Rheumatol. 2018;45:1651\u20135.","journal-title":"J Rheumatol"},{"key":"347_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/art.24003","volume":"59","author":"YA de Man","year":"2008","unstructured":"de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241\u20138.","journal-title":"Arthritis Rheum"},{"key":"347_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3899\/jrheum.180226","volume":"46","author":"H Jethwa","year":"2019","unstructured":"Jethwa H, Lam S, Smith C, Giles I. Does rheumatoid arthritis really improve during pregnancy? A Systematic review and metaanalysis. J Rheumatol. 2019;46:245\u201350.","journal-title":"J Rheumatol"},{"key":"347_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archderm.141.5.601","volume":"141","author":"JE Murase","year":"2005","unstructured":"Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005;141:601\u20136.","journal-title":"Arch Dermatol"},{"key":"347_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.semarthrit.2017.01.002","volume":"46","author":"A Polachek","year":"2017","unstructured":"Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum. 2017;46:740\u20135.","journal-title":"Semin Arthritis Rheum"},{"key":"347_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/ard.2003.016881","volume":"63","author":"M \u00d8stensen","year":"2004","unstructured":"\u00d8stensen M, Fuhrer L, Mathieu R, Seitz M, Villiger PM. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis. 2004;63:1212\u20137.","journal-title":"Ann Rheum Dis"},{"key":"347_CR17","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/rheumatology\/key047","volume":"57","author":"K Ursin","year":"2018","unstructured":"Ursin K, Lydersen S, Skomsvoll JF, Wallenius M. Disease activity during and after pregnancy in women with axial spondyloarthritis: a prospective multicentre study. Rheumatology (Oxford). 2018;57:1064\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"347_CR18","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s12325-020-01448-1","volume":"37","author":"M Mouyis","year":"2020","unstructured":"Mouyis M. Postnatal care of woman with rheumatic diseases. Adv Ther. 2020;37:3723\u201331.","journal-title":"Adv Ther"},{"key":"347_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795\u2013810.","journal-title":"Ann Rheum Dis"},{"key":"347_CR20","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A, Gelfand JM, Connor C, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020;82:1445\u201386.","journal-title":"J Am Acad Dermatol"},{"key":"347_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"347_CR22","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/jdv.13354","volume":"29","author":"A Nast","year":"2015","unstructured":"Nast A, Gisondi P, Ormerod AD, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris\u2014Update 2015\u2014Short version\u2014EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015;29:2277\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"347_CR23","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/jdv.14454","volume":"31","author":"A Nast","year":"2017","unstructured":"Nast A, Spuls PI, van der Kraaij G, et al. European S3-Guideline on the systemic treatment of psoriasis vulgaris\u2014Update Apremilast and Secukinumab\u2014EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2017;31:1951\u201363.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"347_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323\u201337.","journal-title":"J Clin Epidemiol"},{"key":"347_CR25","first-page":"472","volume":"117","author":"HF Wiegand","year":"2020","unstructured":"Wiegand HF, Saam J, Marschall U, et al. Challenges in the transition from in-patient to out-patient treatment in depression. Deutsches Arzteblatt Int. 2020;117:472\u20139.","journal-title":"Deutsches Arzteblatt Int"},{"key":"347_CR26","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften\u2014Leitlinie Vorgehen bei Termin\u00fcberschreitung und \u00dcbertragung. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/015-065l_S1_Termin%C3%BCberschreitung_%C3%9Cbertragung_02-2014-verlaengert_01.pdf. Accessed June 2021."},{"key":"347_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/acr.20422","volume":"63","author":"B Kuriya","year":"2011","unstructured":"Kuriya B, Hern\u00e1ndez-D\u00edaz S, Liu J, Bermas BL, Daniel G, Solomon DH. Patterns of medication use during pregnancy in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011;63:721\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"347_CR28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/art.39521","volume":"68","author":"RJ Desai","year":"2016","unstructured":"Desai RJ, Huybrechts KF, Bateman BT, et al. Brief report: patterns and secular trends in use of immunomodulatory agents during pregnancy in women with rheumatic conditions. Arthritis Rheumatol. 2016;68:1183\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"347_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/acr.23434","volume":"70","author":"NW Tsao","year":"2018","unstructured":"Tsao NW, Lynd LD, Sadatsafavi M, Hanley G, De Vera MA. Patterns of biologics utilization and discontinuation before and during pregnancy in women with autoimmune diseases: a population-based cohort study. Arthritis Care Res (Hoboken). 2018;70:979\u201386.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"347_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/pds.4410","volume":"27","author":"K Palmsten","year":"2018","unstructured":"Palmsten K, Rolland M, Hebert MF, et al. Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: daily and cumulative dose. Pharmacoepidemiol Drug Saf. 2018;27:430\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"347_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/pds.5030","volume":"29","author":"V Belleudi","year":"2020","unstructured":"Belleudi V, Poggi FR, Perna S, et al. Drug discontinuation in pregnant women with psoriasis: the PSO-MOTHER cohort study. Pharmacoepidemiol Drug Saf. 2020;29:904\u201312.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"347_CR32","first-page":"866","volume":"77","author":"A Tincani","year":"2018","unstructured":"Tincani A, Taylor P, Fischer-Betz R, Ecoffet C, Chakravarty E. FRI0693 Fears and misconceptions of women with chronic rheumatic diseases on their journey to motherhood. Ann Rheum Dis. 2018;77:866.","journal-title":"Ann Rheum Dis"},{"key":"347_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/acr.22516","volume":"67","author":"A Kavanaugh","year":"2015","unstructured":"Kavanaugh A, Cush JJ, Ahmed MS, et al. Proceedings from the American college of rheumatology reproductive health summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis Care Res (Hoboken). 2015;67:313\u201325.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"347_CR34","unstructured":"Embryotox\u2014Drug safety in pregnancy and lactation. https:\/\/www.embryotox.de\/. Accessed Sept 2020."},{"key":"347_CR35","first-page":"4933","volume":"86","author":"IJ Elenkov","year":"2001","unstructured":"Elenkov IJ, Wilder RL, Bakalov VK, et al. IL-12, TNF-\u03b1, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab. 2001;86:4933\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"347_CR36","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2214-109X(18)30451-0","volume":"7","author":"S Chawanpaiboon","year":"2019","unstructured":"Chawanpaiboon S, Vogel JP, Moller A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7:e37\u201346.","journal-title":"Lancet Glob Health"},{"key":"347_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/annrheumdis-2020-218356","volume":"80","author":"Y Meissner","year":"2021","unstructured":"Meissner Y, Fischer-Betz R, Andreoli L, et al. EULAR recommendations for a core data set for pregnancy registries in rheumatology. Ann Rheum Dis. 2021;80:49\u201356.","journal-title":"Ann Rheum Dis"},{"key":"347_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-019-2019-3","volume":"21","author":"Y Meissner","year":"2019","unstructured":"Meissner Y, Strangfeld A, Costedoat-Chalumeau N, et al. European Network of Pregnancy Registers in Rheumatology (EuNeP)\u2014an overview of procedures and data collection. Arthritis Res Ther. 2019;21:241.","journal-title":"Arthritis Res Ther"},{"key":"347_CR39","doi-asserted-by":"publisher","first-page":"15556","DOI":"10.1038\/s41598-019-52015-w","volume":"9","author":"BYL Thanh","year":"2019","unstructured":"Thanh BYL, Lumbiganon P, Pattanittum P, et al. Mode of delivery and pregnancy outcomes in preterm birth: a secondary analysis of the WHO Global and Multi-country Surveys. Sci Rep. 2019;9:15556.","journal-title":"Sci Rep"},{"key":"347_CR40","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1093\/humrep\/det297","volume":"28","author":"AM Jukic","year":"2013","unstructured":"Jukic AM, Baird DD, Weinberg CR, McConnaughey DR, Wilcox AJ. Length of human pregnancy and contributors to its natural variation. Hum Reprod (Oxford, England). 2013;28:2848\u201355.","journal-title":"Hum Reprod (Oxford, England)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00347-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T15:25:37Z","timestamp":1699370737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00347-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00347-3","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}